PGPCX
Price
$27.73
Change
+$0.11 (+0.40%)
Updated
Sep 15 closing price
Net Assets
2.29B
RLBCX
Price
$38.39
Change
+$0.07 (+0.18%)
Updated
Sep 15 closing price
Net Assets
263.06B
Interact to see
Advertisement

PGPCX vs RLBCX

Header iconPGPCX vs RLBCX Comparison
Open Charts PGPCX vs RLBCXBanner chart's image
George Putnam Balanced C
Price$27.73
Change+$0.11 (+0.40%)
VolumeN/A
Net Assets2.29B
American Funds American Balanced R3
Price$38.39
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets263.06B
PGPCX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGPCX vs. RLBCX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGPCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 263B vs. PGPCX (2.29B). RLBCX pays higher dividends than PGPCX: RLBCX (1.53) vs PGPCX (0.93). PGPCX was incepted earlier than RLBCX: PGPCX (26 years) vs RLBCX (23 years). PGPCX (1.68) is less costly to investors than RLBCX (0.89). PGPCX is a more actively managed with annual turnover of: 80.00 vs. RLBCX (44.00). PGPCX has a lower initial minimum investment than RLBCX: PGPCX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 9.50 vs. PGPCX (8.37). RLBCX return over 5 years is better than : 40.28 vs. PGPCX (28.66).
PGPCXRLBCXPGPCX / RLBCX
Total Expense Ratio1.680.89189%
Annual Report Gross Expense Ratio1.680.89189%
Fund Existence26 years23 years-
Gain YTD9.72113.07174%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.29B263B1%
Annual Yield % from dividends0.931.5361%
Returns for 1 year8.379.5088%
Returns for 3 years43.6142.14103%
Returns for 5 years28.6640.2871%
Returns for 10 years80.0876.06105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNC11.370.20
+1.79%
Wabash National Corp
NGVT58.690.54
+0.93%
Ingevity Corp
APVO1.44-0.03
-2.04%
Aptevo Therapeutics Inc
INCR1.53-0.04
-2.40%
Intercure Ltd
BAH101.62-3.00
-2.87%
Booz Allen Hamilton Holding Corp